Watchlist Price Alert

Pharming Group N.V. (PHAR)

NASDAQ: PHAR · Real-Time Price · USD

10.75

-0.81 (-7.05%)

At close: Jun 13, 2025, 3:48 PM

10.75

0.01%

After-hours: Jun 13, 2025, 04:00 PM EDT

Pharming Income Statement

Financials in EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	297.2M	245.32M	205.62M	189.85M	228.39M	189.33M	154.58M	107.52M	16.69M
Cost of Revenue	35.4M	25.21M	17.56M	20.18M	25.34M	23.92M	25.37M	14.93M	4.93M
Gross Profit	252.72M	220.1M	188.06M	169.67M	203.06M	165.41M	129.2M	92.59M	11.77M
Operating Income	-8.32M	-4.88M	18.23M	27.84M	82.09M	68.23M	43.46M	26.29M	-12.14M
Interest Income	5.72M	3.53M	85K	14.23M	769.95K	1.13M	20.59K	3.6K	5.26K
Pretax Income	-8.22M	-12.01M	14.99M	22.03M	47.47M	52.29M	980.32K	-107.25M	-18.44M
Net Income	-10.64M	-10.55M	13.67M	16M	37.75M	40.54M	28.59M	-95.92M	-18.44M
Selling & General & Admin	99.22M	87.5M	131.82M	92.05M	69.97M	65.9M	53.49M	44.86M	8.07M
Research & Development	83.15M	68.91M	52.53M	67.18M	41.46M	31.78M	33.04M	22.38M	16.18M
Other Expenses	88.06M	69.08M	-14.52M	-2.5M	9.54M	-487.27K	-684K	-790K	-335K
Operating Expenses	270.42M	225.49M	169.83M	156.72M	120.97M	97.19M	85.74M	66.3M	23.91M
Interest Expense	8.74M	5.96M	5.36M	5.92M	6.4M	13.35M	16.37M	21.28M	3.77M
Selling & Marketing Expenses	7.13M	6.82M	85.8M	56.75M	55.55M	44.71M	39.51M	37.7M	3.19M
Cost & Expenses	295.21M	250.7M	187.39M	176.91M	146.31M	121.11M	111.12M	81.23M	28.83M
Income Tax Expense	2.43M	-1.46M	1.31M	6.76M	6.83M	11.74M	-27.61M	-11.33M	3.77M
Shares Outstanding (Basic)	68.92M	65.7M	88.39M	87.64M	85.34M	84.19M	81.69M	62.55M	51.92M
Shares Outstanding (Diluted)	68.92M	65.7M	88.39M	87.64M	85.34M	84.19M	81.69M	62.55M	51.92M
EPS (Basic)	-0.15	-0.14	0.17	0.20	0.46	0.52	0.35	-1.54	-0.35
EPS (Diluted)	-0.15	-0.14	0.15	0.18	0.44	0.48	0.35	-1.54	-0.35
EBITDA	7.19M	9.88M	33.53M	48.78M	92.11M	71.46M	50.98M	-39.81M	-13.88M
EBIT	245K	-6.05M	20.34M	29.17M	50.04M	65.66M	17.35M	-80.43M	-14.67M
Depreciation & Amortization	15.51M	15.93M	13.19M	19.61M	8.31M	5.8M	7.5M	4.1M	795.09K